INTRODUCTION Autism spectrum disorder (ASD) is a lifelong neurodevelop-mental condition characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests, or activities [1]. The prevalence of ASD has increased markedly in the recent three decades and the median of prevalence estimates of ASD was 62/10,000 [2]. In 2014, the Centers for Disease Control and Prevention (CDC) estimated that ASD affects approximately 1 in 68 children [3]. Although increases in public awareness and research funding have led to scientific advances in understanding ASD and its treatment, there is a huge unmet demand for mechanism-driven successful interventions of core symptoms of ASD. Pharmacological treatments such as ris-peridone and aripiprazole can be beneficial in relieving some symptoms of ASD, but drugs for improvement of the core symptoms are yet to be developed [4]. Brain stimulation and modulation has long been implemented in the treatment of psychiatric disorders and guidelines were suggested for several brain stimulation methods, such as electrocon-vulsive therapy (ECT), single-pulse or repeated transcranial magnetic stimulation (rTMS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), et cetera [5]. Brain stimulation, unlike systemic pharmacological treatment delivered orally or parenter-ally, involves electrical mechanisms of the brain, which in turn induces localized neurochemical changes [5]. Applications of neuro-stimulation or neuromodulation by a variety of new and old techniques might be able to improve or correct underlying dysfunc-tions. Although brain stimulation therapies have been regarded as highly invasive treatment and reserved for patients with treatment-resistant disorders, several new stimulation methods are less inva-sive and can be used in less severe patients. Therapeutic applications of these tools in ASD have been tried in some cases but clinical experience and scientific evidence are limited (Table 1). Here Hanyang Med Rev 2016;36:65-71 http://dx. Autism spectrum disorder (ASD) is characterized by a range of conditions including impairments in social interaction, communication, and restricted and repetitive behaviors. Pharmacological treatments can improve some symptoms of ASD, but the effect is limited and there is a huge unmet demand for successful interventions of ASD. Brain stimulation and modulation are emerging treatment options for ASD: electroconvulsive therapy for catato-nia in ASD, vagal nerve stimulation for comorbid epilepsy and ASD, and deep brain stimulation for serious self-injurious behavior. Therapeutic tools are evolving to mechanism-driven treatment. Excitation/Inhibition (E/I) imbalance alters the brain mechanism of information processing and behavioral regulation. Repetitive transcranial magnetic stimulation can stabilize aberrant neuroplasticity by improving E/I balance. These brain stimulation and modulation methods are expected to be used for exploration of the pathophysiology and etiology ...